Gary Owens, MD, president of Gary Owens Associates, discusses current treatments available for pulmonary arterial hypertension (PAH) and where future directions in research may lead.
In the future, we hope to see the development of disease-modifying agents for pulmonary arterial hypertension (PAH), said Gary Owens, MD, president of Gary Owens Associates.
Transcript:
What do you hope to see with regard to research on PAH within the next 5 years?
The good news is within the last, I would say, decade-plus, maybe 2 decades, we've really come a long way in understanding this disease. And our treatments really fall into just a handful of categories: endothelin receptor antagonists, PDE5 inhibitors, soluble guanylate cyclase stimulators, and prostacyclin therapies, whether that be administering prostacyclins, or administering receptor antagonists. And we now know that if you stratify patients according to risk, and those with moderate to high risk begin on either dual or triple therapy, the outcomes are better. So that's where are we are now.
But what can we think about in future directions? I think we'd like to see disease-modifying agents that really can maybe even reverse the course of the disease. Right now, what we can do is modify the progression of the disease. We're also understanding a lot more about the pathophysiology of this disease, and we're learning a lot about some new targets for treating this disease, so that becomes important. Targets that we're looking at, we're looking at vasointestinal polypeptide signaling, for instance. We're looking at PDGF signaling, for instance. We're looking at even estrogen signaling, and even the Nrf2 pathway that we're learning a lot about is something that we're learning more about. So I think there are lots of things that we're beginning to understand in this disease and looking at new directions.
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Initiating BP Medication Linked to Higher Fall, Fracture Risks in Nursing Home Residents
May 2nd 2024Among over 60,000 nursing home residents who initiated antihypertensive medication, rates of excess fractures due to falls per 100 person-years were as high as 5 among certain patient groups, such as those with dementia and high blood pressure (BP).
Read More